nach oben

International Journal of Mental Health and Addiction

Erschienen in:

09.08.2021 | Original Article

Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned

verfasst von: Hailey Judd, Cristian L. Meier, Ashley C. Yaugher, Emma Campbell, Kandice Atismé-Bevins

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Stigma towards substance use continues to exacerbate the opioid crisis and its detrimental effects, claiming tens of thousands of lives each year. Reducing substance use stigma through evidence-based techniques is crucial to overcoming and eliminating stigma’s imposed barriers. This study, conducted in the USA, employed semi-structured interview transcripts of 32 adults with lived experience of opioid use disorder (OUD), professionals, and family members were analyzed using an inductive thematic approach to identify overarching themes for OUD stigma reduction strategies. Utilizing this lived-experience framework revealed methods to address stigma through interpersonal communication and social interactions. Specifically, using less stigmatizing language, addressing perceptions of persons who experience OUD, employing open communication about OUD to change narratives and beliefs through incorporating messages of hope and recovery, and replacing stigma with empathy and compassion to support recovery. Utilizing individuals with lived experience of OUD offered first-hand insight to identify potential solutions, advance existing literature, and ultimately combat the opioid crisis.

Ashford, R. D., Brown, A. M., Canode, B., McDaniel, J., & Curtis, B. (2019). A mixed-methods exploration of the role and impact of stigma and advocacy on substance use disorder recovery. Alcoholism Treatment Quarterly, 37(4), 462–480. https://doi.org/10.1080/07347324.2019.1585216CrossRef

Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oaCrossRef

Buckingham, S., Frings, D., & Albery, I. (2013). Group membership and social identity in addiction recovery. Psychology of Addictive Behaviors, 27(4)https://doi.org/10.1037/a0032480

Centers for Disease Control and Prevention (CDC). (n.d.-a). Know your options. Retrieved March 9, 2020 from https://www.cdc.gov/drugoverdose/patients/options.html

Centers for Disease Control and Prevention (CDC). (n.d.-b). Prevent opioid misuse. Retrieved March 9, 2021 from https://www.cdc.gov/drugoverdose/patients/prevent-misuse.html

Centers for Disease Control and Prevention (CDC). (2017). Opioid prescribing: Where you live matters. CDC Vitalsigns. Retrieved March 10, 2021 from https://www.cdc.gov/vitalsigns/pdf/2017-07-vitalsigns.pdf

Corrigan, P. W., & Watson, A. C. (2002). Understanding the impact of stigma on people with mental illness. World Psychiatry, 1(1), 16–20.

Corrigan, P., Kerr, A., & Knudsen, L. (2005). The stigma of mental illness: Explanatory models and methods for change. Applied and Preventive Psychology, 11(3), 179–190. https://doi.org/10.1016/j.appsy.2005.07.001CrossRef

Corrigan, P., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane-Willis, K., Qin, S., & Smelson, D. (2017a). Developing a research agenda for understanding the stigma of addictions part I: Lessons from the mental health stigma literature. The American Journal of Addictions, 26(1), 59–66. https://doi.org/10.1111/ajad.12458CrossRef

Corrigan, P., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane-Willis, K., Qin, S., & Smelson, D. (2017b). Developing a research agenda for understanding the stigma of addictions part II: Lessons from the mental health stigma literature. The American Journal of Addiction, 26(1), 67–74. https://doi.org/10.1111/ajad.12436CrossRef

Crapanzano, K., Vath, R. J., & Fisher, D. (2014). Reducing stigma towards substance users through an education intervention: Harder than it looks. Academic Psychiatry, 38(4), 420–425. https://doi.org/10.1007/s40596-014-0067-1CrossRef

Crocker, A. F., & Smith, S. N. (2019). Person-first language: Are we practicing what we preach? Journal of Multidisciplinary Healthcare, 12, 125–129. https://doi.org/10.2147/JMDH.S140067CrossRef

da Silveira, P. S., Casela, A. L. M., Monteiro, E. P., Ferreira, G. C. L., de Freitas, J. V. T., Machado, N. M., Noto, A. R., & Ronzani, T. M. (2018). Psychosocial understanding of self-stigma among people who seek treatment for drug addiction. Stigma and Health, 3(1), 42–52. https://doi.org/10.1037/sah0000069CrossRef

Dobkin, P. L., Civita, M. D., Paraherakis, A., & Gill, K. (2002). The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction, 97(3), 347–356. https://doi.org/10.1046/j.1360-0443.2002.00083.xCrossRef

Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain – United States, 2016. Journal of the American Medical Association, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464CrossRef

Earnshaw, V. A., & Quinn, D. M. (2012). The impact of stigma in healthcare on people living with chronic illnesses. Journal of Health Psychology, 17(2), 157–168. https://doi.org/10.1177/1359105311414952CrossRef

Earnshaw, V. A., Bogart, L. M., Menino, D. D., Kelly, J. F., Chaudoir, S. R., Reed, N. M., & Levy, S. (2019). Disclosure, stigma, and social support among young people receiving treatment for substance use disorders and their caregivers: A qualitative analysis. International Journal of Mental Health Addiction, 17, 1535–1549. https://doi.org/10.1007/s11469-018-9930-8CrossRef

Fereday, J., & Muir-Cochrane, E. (2006). Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development. International Journal of Qualitative Methods, 5(1), 80–92. https://doi.org/10.1177/160940690600500107CrossRef

Florence, C., Luo, F., & Rice, K. (2021) The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug and Alcohol Dependence, 218(1) https://doi.org/10.1016/j.drugalcdep.2020.108350

Food and Drug Administration. (2016). What to ask your doctor before taking opioids. https://www.fda.gov/consumers/consumer-updates/what-ask-your-doctor-taking-opioids

Garland, E. L., Pettus-Davis, C., & Howard, M. O. (2013). Self-medication among traumatized youth: Structural equation modeling of pathways between trauma history, substance misuse, and psychological distress. Journal of Behavioral Medicine, 36(2), 175–185. https://doi.org/10.1007/s10865-012-9413-5CrossRef

Green, B., Jones, K., Lyerla, R., Dyar, W., & Skidmore, M. (2020). Stigma and behavioral health literacy among individuals with proximity to mental health or substance use conditions. Journal of Mental Health, 1-7. Advance online publication https://doi.org/10.1080/09638237.2020.1713998

Hall, E. A., Cernasev, A., Nasritdinova, U., Veve, M. P., & Hohmeier, K. C. (2020). Stigma of opioid use disorder and its indirect effects on student pharmacists’ perceptions and attitudes. Pharmacy, 8(3), 144. https://doi.org/10.3390/pharmacy8030144CrossRef

Hall, N. Y., Le, L., Majmudar, I., & Mihalopoulos, C. (2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence, 221, 208651. Advance online publicationhttps://doi.org/10.1016/j.drugalcdep.2021.108651

Hedegaard, H., Warner, M., & Miniño, A. M. (2016). Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017/CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC. National Center for Health Statistics, 901–906

Hedegaard, H., Miniño, A. M., & Warner, M. (2020). Drug overdose deaths in the United States, 1999-2018. NCHS data brief, no 76. Hyattsville, MD: National Center for Health Statistics

Jonsen, K., & Jehn, K. A. (2009). Using triangulation to validate themes in qualitative studies. Qualitative Research in Organizations and Management: An International Journal

Kelly, J. F., & Westerhoff, C. M. (2010). Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. International Journal of Drug Policy, 21(3), 202–207. https://doi.org/10.1016/j.drugpo.2009.10.010CrossRef

Kelly, J. F., Saitz, R., & Wakeman, S. (2016). Language, substance use disorders, and policy: The need to reach consensus on an “addiction-ary.” Alcoholism Treatment Quarterly, 34(1), 116–123. https://doi.org/10.1080/07347324.2016.1113103CrossRef

Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health-oriented policies. Psychiatric Services, 68(5), 462–469. https://doi.org/10.1176/appi.ps.201600056CrossRef

Kulesza, M., Watkins, K. E., Ober, A. J., Osilla, K. C., & Ewing, B. (2017). Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support. Drug and Alcohol Dependence, 180, 52–55. https://doi.org/10.1016/j.drugalcdep.2017.08.002CrossRef

Latkin, C., Davey-Rothwell, M., Yang, J. Y., & Crawford, N. (2013). The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. Journal of Urban Health, 90(1), 147–156. https://doi.org/10.1007/s11524-012-9753-zCrossRef

Leece, P., Khorasheh, T., Paul, N., Keller-Olaman, S., Massarella, S., Caldwell, J., Parkinson, M., Strike, C., Taha, S., Penney, G., Henderson, R., & Manson, H. (2019). ‘Communities are attempting to tackle the crisis’: A scoping review on community plans to prevent and reduce opioid-related harms. British Medical Journal Open, 9(9), e028583. https://doi.org/10.1136/bmjopen-2018-028583CrossRef

Leeies, M., Pagura, J., Sareen, J., & Bolton, J. M. (2010). The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder. Depression and Anxiety, 27(8), 731–736. https://doi.org/10.1002/da.20677CrossRef

Lewis, L. F., & Jarvis, L. (2019). Undergraduate nursing students’ experiences and attitudes towards working with patients with opioid use disorder in the clinical setting: A qualitative content analysis. Nurse Education Today, 73, 17–22. https://doi.org/10.1016/j.nedt.2018.11.001CrossRef

Link, B. G., & Phelan, J. C. (2006). Stigma and its public health implications. The Lancet, 367(9509), 528–529. https://doi.org/10.1016/S0140-6736(06)68184-1CrossRef

Link, B. G., Yang, L. H., Phelan, J. C., & Collins, P. Y. (2004). Measuring mental illness stigma. Schizophrenia Bulletin, 30(3), 511–541. https://doi.org/10.1093/oxfordjournals.schbul.a007098CrossRef

Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39–50. https://doi.org/10.1111/j.1360-0443.2011.03601.xCrossRef

Luoma, J. B., Kohlenberg, B. S., Hayes, S. C., & Fletcher, L. (2012). Slow and steady wins the race: A randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders. Journal of Consulting and Clinical Psychology, 80(1), 43–53. https://doi.org/10.1037/a0026070CrossRef

Luoma, J. B., Kohlenberg, B. S., Hayes, S. C., Bunting, K., & Rye, A. K. (2008). Reducing self-stigma in substance abuse through acceptance and commitment therapy: Model, manual development, and pilot outcomes. Addiction Research & Theory, 16(2), 149–165. https://doi.org/10.1080/16066350701850295CrossRef

Luoma, J. B., Kulesza, M., Hayes, S. C., Kohlenberg, B., & Larimer, M. (2014). Stigma predicts residential treatment length for substance use disorder. The American Journal of Drug and Alcohol Abuse, 40(3), 206–212. https://doi.org/10.3109/00952990.2014.901337CrossRef

McGinty, E. E., & Barry, C. L. (2020). Stigma reduction to combat the addiction crisis – Developing an evidence base. The New England Journal of Medicine, 382(14), 1291–1292. https://doi.org/10.1056/NEJMp2000227CrossRef

McGinty, E. E., Goldman, H. H., Pescosolido, B., & Barry, C. L. (2015). Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination. Social Science & Medicine, 126, 73–85. https://doi.org/10.1016/j.socscimed.2014.12.010CrossRef

McGinty, E., Pescosolido, B., Kennedy-Hendricks, A., & Barry, C. L. (2018). Communication strategies to counter stigma and improve mental illness and substance use disorder policy. Psychiatric Services, 69(2), 136–146. https://doi.org/10.1176/appi.ps.201700076CrossRef

Morone, N. E., & Weiner, D. K. (2013). Pain as the fifth vital sign: Exposing the vital need for pain education. Clinical Therapeutics, 35(11), 1728–1732. https://doi.org/10.1016/j.clinthera.2013.10.001CrossRef

Moser, A., & Korstjens, I. (2018). Series: Practical guidance to qualitative research Part 3: Sampling, data collection and analysis. European Journal of General Practice, 24(1), 9–18. https://doi.org/10.1080/13814788.2017.1375091CrossRef

National Institute on Drug Abuse. (2020). Opioid overdose crisis. https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis

O’Connor, C., & Joffe, H. (2020). Intercoder reliability in qualitative research: Debates and practical guidelines. International Journal of Qualitative Methods, 19, 1609406919899220. https://doi.org/10.1177/1609406919899220CrossRef

Olsen, Y., & Sharfstein, J. M. (2014). Confronting the stigma of opioid use disorder—and its treatment. Journal of the American Medical Association, 311(14), 1393–1394. https://doi.org/10.1001/jama.2014.2147CrossRef

Parker, A. M., Strunk, D., & Fiellin, D. A. (2018). State responses to the opioid crisis. Journal of Law, Medicine & Ethics, 46(2), 367–381. https://doi.org/10.1177/1073110518782946CrossRef

Saldaña, J. (2021). The coding manual for qualitative researchers (4th ed.). Sage Publishing

Saloner, B., McGinty, E. E., Beletsky, L., Bluthenthal, R., Beyrer, C., Botticelli, M., & Sherman, S. G. (2018). A public health strategy for the opioid crisis. Public Health Reports, 133I(I), 24S-34S. https://doi.org/10.1177/0033354918793627CrossRef

Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths –United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(51 & 52), 1419–1427.

Schomerus, G., & Angermeyer, M. C. (2008). Stigma and its impact on help-seeking for mental disorders: What do we know? Epidemiology and Psychiatric Services, 17(1), 31–37. https://doi.org/10.1017/s1121189x00002669CrossRef

Simoni, J. M., Weinberg, B. A., & Nero, D. K. (1999). Training community members to conduct survey interviews: Notes from a study of seropositive women. AIDS Education and Prevention, 11(1), 87–88.

Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration

Thomas, D. R. (2017). Feedback from research participants: Are member checks useful in qualitative research? Qualitative Research in Psychology, 14(1), 23–41. https://doi.org/10.1080/14780887.2016.1219435CrossRef

Stuart, H. (2019). Managing the stigma of opioid use. Healthcare Management Forum, 32(2), 78–83. https://doi.org/10.1177/0840470418798658CrossRef

Utah Department of Health. (2019). Utah opioid overdose fatality review hotspots report: March 2019. Salt Lake City, UT. Violence and Injury Prevention Program. http://health.utah.gov/vipp/pdf/RxDrugs/OFRCHotSpots2019.pdf

van Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013). Stigma among health professionals towards patients with substance use disorders and its consequence for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131, 23–35. https://doi.org/10.1016/j.drugalcdep.2013.02.018CrossRef

Van Zee, A. (2009). The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. American Journal of Public Health, 99(2), 2210227. https://doi.org/10.2105/AJPH.2007.131714CrossRef

Wickramatilake, S., Zur, J., Mulvaney-Day, N., von Kilmo, M. C. E., Selmi, & Harwood, H. (2017). How states are tackling the opioid crisis. Public Heath Reports,132(2), 171–179. https://doi.org/10.1177/0033354916688206CrossRef

Woo, J., Bhalerao, A., Bawor, M., Bhatt, M., Dennis, B., Mouravska, N., Zielinski, L., & Samaan, Z. (2017). “Don’t judge a book by its cover”: A qualitative study of methadone patients’ experiences of stigma. Substance Abuse: Research and Treatment,11, 1178221816685087. https://doi.org/10.1177/1178221816685087CrossRef

Titel: Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned
verfasst von: Hailey Judd
Cristian L. Meier
Ashley C. Yaugher
Emma Campbell
Kandice Atismé-Bevins
Publikationsdatum: 09.08.2021
Verlag: Springer US
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 1/2023
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-021-00606-y

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned

Abstract

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

Wartezeit nicht kürzer, aber Arbeit flexibler

Chirurginnen und Chirurgen sind stark suizidgefährdet

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Psychiatrie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Evaluation of the English Version of the Fear of COVID-19 Scale and Its Relationship with Behavior Change and Political Beliefs

Correction to: Malay Version of the Fear of COVID-19 Scale: Validity and Reliability

Dropout or Early Treatment Response Among Gamblers with Depressive Symptoms

Factors Associated with Recovery and Flourishing Mental Health in a National Sample of Canadians with a History of Illicit Drug Dependence

Social Media Addiction and Mental Health Among University Students During the COVID-19 Pandemic in Indonesia

Incarceration Trajectories and Mental Health Problems Among Mothers Imprisoned in State and Federal Correctional Facilities: A Nationwide Study

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

Wartezeit nicht kürzer, aber Arbeit flexibler

Chirurginnen und Chirurgen sind stark suizidgefährdet

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Psychiatrie